Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Neuro Oncol ; 16(1): 140-6, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24285547

RESUMO

INTRODUCTION: Mutations in H3F3A, which encodes histone H3.3, commonly occur in pediatric glioblastoma. Additionally, H3F3A K27M substitutions occur in gliomas that arise at midline locations (eg, pons, thalamus, spine); moreover, this substitution occurs mainly in tumors in children and adolescents. Here, we sought to determine the association between H3F3A mutations and adult thalamic glioma. METHODS: Genomic H3F3A was sequenced from 20 separate thalamic gliomas. Additionally, for 14 of the 20 gliomas, 639 genes--including cancer-related genes and chromatin-modifier genes--were sequenced, and the Infinium HumanMethylation450K BeadChip was used to examine DNA methylation across the genome. RESULTS: Of the 20 tumors, 18 were high-grade thalamic gliomas, and of these 18, 11 were from patients under 50 years of age (median age, 38 y; range, 17-46), and 7 were from patients over 50 years of age. The H3F3A K27M mutation was present in 10 of the 11 (91%) younger patients and absent from all 7 older patients. Additionally, H3F3A K27M was not detected in the 2 diffuse astrocytomas. Further sequencing revealed recurrent mutations in TP53, ATRX, NF1, and EGFR. Gliomas with H3F3A K27M from pediatric or young adult patients had similar, characteristic DNA methylation profiles. In contrast, thalamic gliomas with wild-type H3F3A had DNA methylation profiles similar to those of hemispheric glioblastomas. CONCLUSION: We found that high-grade thalamic gliomas from young adults, like those from children and adolescents, frequently had H3F3A K27M.


Assuntos
Biomarcadores Tumorais/genética , Neoplasias Encefálicas/genética , Glioma/genética , Histonas/genética , Mutação/genética , Doenças Talâmicas/genética , Adolescente , Adulto , Idoso , Neoplasias Encefálicas/mortalidade , Neoplasias Encefálicas/patologia , Metilação de DNA , Feminino , Seguimentos , Glioma/mortalidade , Glioma/patologia , Humanos , Masculino , Pessoa de Meia-Idade , Gradação de Tumores , Prognóstico , Taxa de Sobrevida , Doenças Talâmicas/mortalidade , Doenças Talâmicas/patologia , Adulto Jovem
2.
Surg Neurol ; 70(6): 628-33, 2008 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-18207500

RESUMO

BACKGROUND: The decision to administer conservative or surgical treatment for putaminal and thalamic ICH is still a controversial issue. This study was undertaken to examine the decision-making criteria for these 2 treatments. METHODS: In a retrospective study, case records of 400 patients with spontaneous putaminal and thalamic hemorrhage who underwent conservative treatment (n = 201) and surgical treatment (n = 199) over the past 5 years were examined. Conservative treatment included hypertonic solution treatment and hypertension control. Surgical treatments included endoscopic surgery, craniotomy, and stereotactic aspiration. Preoperative GCS score and ICH volume were the major evaluating factors, and comparison of the 30-day mortality rate and 6-month BI score was used for outcome evaluation. RESULTS: In patients with a GCS score of 13 to 15, there was no difference in mortality between conservative and surgical treatments. At a GCS score of 9 to 12 and ICH volume of less than 30 mL, the mortality rate with surgical treatment (10.5%) was lower than that with conservative treatment (20.0%, P < .05). At a GCS score of 3 to 8 and ICH volume of at least 30 mL, surgical treatment was for life saving. Mortality rates were lower for conservative treatment than for surgical treatment when the GCS score was 3 to 12 and ICH volume less than 30 mL. Endoscopic surgery had a better functional outcome compared with craniotomy and stereotactic aspiration when the GCS score was at least 9 (P < .001 and P < .02, respectively). Those in conservative treatment received a better BI score than those in surgical treatment did when the ICH volume was less than 40 mL (P < .001). CONCLUSIONS: Intracerebral hemorrhage volume is probably more important than GCS score in determining treatment. Our nonrandomized data could be interpreted to show that conservative treatment is suggested at GCS score of at least 13 or when ICH volume is less than 30 mL, regardless of GCS score. Surgical treatment could be recommended at GCS score of less than 12 with ICH volume of at least 30 mL for life saving. Endoscopic surgery may improve the functional outcomes because it is less invasive and effectively removes the ICH at GCS score of at least 9.


Assuntos
Hematoma/terapia , Hemorragia Putaminal/terapia , Doenças Talâmicas/terapia , Adulto , Idoso , Idoso de 80 Anos ou mais , Estudos de Coortes , Craniotomia , Endoscopia , Feminino , Escala de Coma de Glasgow , Hematoma/mortalidade , Hematoma/patologia , Humanos , Masculino , Pessoa de Meia-Idade , Valor Preditivo dos Testes , Hemorragia Putaminal/mortalidade , Hemorragia Putaminal/patologia , Estudos Retrospectivos , Técnicas Estereotáxicas , Doenças Talâmicas/mortalidade , Doenças Talâmicas/patologia , Resultado do Tratamento
3.
Childs Nerv Syst ; 23(7): 753-60, 2007 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-17370079

RESUMO

OBJECTIVES: Thalamic tumors are uncommon, and although gross total removal (GTR) is a prospective goal, its interest is debated because the thalamus constitutes a highly functional region. The relation of choice of the surgical approach, achievability of GTR, and operative morbidity to the anatomic location of the tumor has received little attention in the medical literature. MATERIALS AND METHODS: We reviewed retrospectively the cases of pediatric patients treated for thalamic tumor, with pre- and postoperative magnetic resonance imaging, and who were operated with the aim of maximal surgical removal. CONCLUSION: We reviewed 16 cases operated between 1992 and 2003. The clinical presentation was dominated by intracranial hypertension and hemiparesis. Fifteen children were operated through transcortical approaches: transfrontal in six cases, transparietal in six, and transtemporal in three. The remaining patient was operated through an infratemporal approach. All operations performed since 1998 used intraoperative neuronavigation. Complete or near-total resection was achieved in 11 cases; only subtotal resection was achieved in the remaining five cases. The most common postoperative morbidity was visual field defect. Hemiparesis was unchanged or improved in all the cases. Seven children died of tumor progression, in relation with high histological grade, and one died of acute hydrocephalus. The approach to thalamic tumors needs to be planned according to the location of critical neural structures. GTR of thalamic tumors in children bears acceptable morbidity and may even improve preoperative deficits. Surgery alone can be curative in low-grade tumors; in high-grade or infiltrating tumors, GTR is only part of the overall oncological management.


Assuntos
Neoplasias Encefálicas/cirurgia , Ventrículos Cerebrais/cirurgia , Procedimentos Neurocirúrgicos/métodos , Doenças Talâmicas/cirurgia , Tálamo/patologia , Adolescente , Neoplasias Encefálicas/mortalidade , Neoplasias Encefálicas/patologia , Criança , Pré-Escolar , Intervalo Livre de Doença , Feminino , Humanos , Imageamento por Ressonância Magnética , Masculino , Neuronavegação , Estudos Retrospectivos , Doenças Talâmicas/mortalidade , Doenças Talâmicas/patologia , Tálamo/cirurgia , Resultado do Tratamento
4.
Neurochirurgie ; 52(1): 3-14, 2006 Feb.
Artigo em Francês | MEDLINE | ID: mdl-16609655

RESUMO

BACKGROUND AND PURPOSE: Pilocytic astrocytoma (PA) is a WHO grade I tumor of the central nervous system mostly arising in children and young adults. Management of diencephalic PA is a difficult challenge. Surgical treatment has to cope with both the difficulties of deep location and eloquent area tumors. MATERIALS AND METHODS: We retrospectively reviewed seven pediatric cases (female: 4, male: 3) of diencephalic PA. Opto-chiasmatic tumors were excluded from the series. Mean age at diagnosis was 108 months (9 years) (range: 4 month-18 years), median age was 111 months. Median follow-up for the series was 125 months. Tumor locations were as followed: right thalamus: 2, both thalami: 1, hypothalamus: 3, and right basal ganglia: 1. At the onset, the first symptom was mostly raised intracranial pressure. The delay in diagnosis ranged from 48 hours up to 6 years. TREATMENT: a shunting procedure was performed in 3 patients, a direct surgical approach in 5 patients (gross total removal: 2; partial removal: 3) and one patient had only a biopsy. Three children were re-operated. Three patients were treated by radiationtherapy (RT) after surgery. Chemotherapy was delivered for 4 children. RESULTS: The overall survival rate was 71.4 months (almost 6 years) (range: 3-184 months). Median survival rate was 42 months (3.5 years). Three children died, two by tumor progression and one death related to late side-effects of RT. Four patients have a good quality of life with GOS I (n = 3) or II (n = 1). We observed tumor regression in two patients at 1 and 17 years after the beginning of treatment. Correct diagnosis was only made for two cases at the initial pathological examination. CONCLUSION: The course of diencephalic PA is still unpredictable. The tumor can be controlled by a partial surgical removal, and a residual tumor can sometimes decrease in size after surgery. Gross total removal of these tumors, although difficult, may be performed. With cranial navigation systems, the risk is low. Pathological diagnosis is sometimes difficult to assess.


Assuntos
Astrocitoma/cirurgia , Neoplasias Encefálicas/cirurgia , Neoplasias Hipotalâmicas/cirurgia , Doenças Talâmicas/cirurgia , Adolescente , Astrocitoma/diagnóstico , Astrocitoma/mortalidade , Astrocitoma/patologia , Neoplasias Encefálicas/diagnóstico , Neoplasias Encefálicas/mortalidade , Neoplasias Encefálicas/patologia , Quimioterapia Adjuvante , Criança , Pré-Escolar , Terapia Combinada , Dominância Cerebral/fisiologia , Feminino , Seguimentos , Humanos , Neoplasias Hipotalâmicas/diagnóstico , Neoplasias Hipotalâmicas/mortalidade , Neoplasias Hipotalâmicas/patologia , Hipotálamo/patologia , Hipotálamo/cirurgia , Lactente , Imageamento por Ressonância Magnética , Masculino , Qualidade de Vida , Radioterapia Adjuvante , Reoperação , Estudos Retrospectivos , Taxa de Sobrevida , Doenças Talâmicas/diagnóstico , Doenças Talâmicas/mortalidade , Doenças Talâmicas/patologia , Tálamo/patologia , Tálamo/cirurgia , Tomografia Computadorizada por Raios X
5.
Neurosurg Rev ; 24(2-3): 108-13, 2001 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-11485230

RESUMO

Acute management of deep-seated hematomas remains controversial. Since patients with these hematoma later tend to develop severe edema and necrosis around the lesion, when surgery is indicated it should be done as early as possible. The purpose of this study was to compare whether early surgical removal and conservative treatment of primary thalamic hematoma correlated with improved neurological outcome. Last year, 61 patients with primary thalamic hematomas were admitted to our institution. Of these, 21 underwent surgery via contralateral transcallosal approach during the ultraearly stage (within 6 hours) after the apoplectic attack, and 24 patients were treated conservatively. Another 16 patients were excluded from the study due to systemic disease, mild hematoma (<40 cc), and deep coma associated with absence of brain stem reflexes. Initial Glasgow coma scores (GCS) at admission were similar for operated and nonoperated patients (8.64 +/- 1.93 versus 9.50 +/- 2.10, P>0.05). In the operated group, two patients had good recoveries and returned to normal life (Glasgow Outcome Score, or GOS, I), four had moderate disability and needed partial care (GOS II), six had severe disability and needed nursing care (GOS III), and six had a vegetative state (GOS IV). However, in the nonoperated group, one patient had good recovery and returned to normal life (GOS I), two had moderate disability and needed partial home care (GOS II), three had severe disability and needed nursing care (GOS III), and six had a vegetative state (GOS IV). In this group, the 30-day mortality rate was 50%. Mortality was markedly lower in the operated group (14.3%) than the nonoperated group. and this difference was statistically significant (chi2=3.33, P<0.05). From this study, we believe that evacuation of primary thalamic hematoma via the contralateral transcallosal microsurgical approach may be useful for deciding on the indication and predicting the functional prognosis.


Assuntos
Dexametasona/uso terapêutico , Hematoma/cirurgia , Doenças Talâmicas/cirurgia , Atividades Cotidianas , Adulto , Idoso , Anti-Inflamatórios/uso terapêutico , Feminino , Seguimentos , Escala de Resultado de Glasgow , Hematoma/tratamento farmacológico , Hematoma/mortalidade , Hematoma/fisiopatologia , Humanos , Tempo de Internação , Masculino , Microcirurgia , Pessoa de Meia-Idade , Recuperação de Função Fisiológica , Doenças Talâmicas/tratamento farmacológico , Doenças Talâmicas/mortalidade , Doenças Talâmicas/fisiopatologia , Fatores de Tempo , Resultado do Tratamento
6.
Childs Nerv Syst ; 13(10): 514-20; discussion 521, 1997 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-9403198

RESUMO

Thalamic tumors (TT) merit individual analysis and must not be confused with tumors that, while involving the entire thalamus have a different origin. We analyzed 26 patients who fulfilled our criteria of having "strictly" TT. We examined incidence, clinical features, histology, response to treatment (mainly surgery), recurrence rate, mortality and prognosis. We considered that histology and surgical treatment were the most important items related to prognosis. Low-grade tumors (LGT) had a good prognosis, while anaplastic tumors (AT) had a discouraging one; nevertheless both must be operated on. We believe that total removal of LGT is curative and total removal of AT, even if it is not curative, can extend survival by some months. Radiotherapy and chemotherapy seemed to be of little value in our series of TT.


Assuntos
Neoplasias Encefálicas/cirurgia , Doenças Talâmicas/cirurgia , Adolescente , Argentina/epidemiologia , Neoplasias Encefálicas/mortalidade , Neoplasias Encefálicas/patologia , Criança , Terapia Combinada , Feminino , Humanos , Masculino , Recidiva Local de Neoplasia/mortalidade , Recidiva Local de Neoplasia/patologia , Recidiva Local de Neoplasia/cirurgia , Estadiamento de Neoplasias , Prognóstico , Taxa de Sobrevida , Doenças Talâmicas/mortalidade , Doenças Talâmicas/patologia , Tálamo/patologia , Tálamo/cirurgia
7.
Neurosurgery ; 35(5): 817-20; discussion 820-1, 1994 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-7838328

RESUMO

The natural history of 70 patients affected by low-grade astrocytomas was recorded after the histological diagnosis was obtained by serial stereotactic biopsy. Forty-three percent of these patients died within 3 years. The value of cell kinetics assessment at the time of stereotactic biopsy was investigated, and the labeling index percent may be considered the most accurate prognostic factor in these histologically homogeneous astrocytomas. It has been confirmed that the young age of patients predicts a more favorable course, but the value of this also seems to be linked to and dependent on cell kinetics. These data are discussed in view of the opportunity to perform more aggressive "cytoreductive" treatments in deep brain tumors when these indices support an expected poor prognosis.


Assuntos
Astrocitoma/patologia , Doenças dos Gânglios da Base/patologia , Neoplasias Encefálicas/patologia , Doenças Talâmicas/patologia , Adolescente , Adulto , Idoso , Astrocitoma/mortalidade , Astrocitoma/cirurgia , Gânglios da Base/patologia , Gânglios da Base/cirurgia , Doenças dos Gânglios da Base/mortalidade , Doenças dos Gânglios da Base/cirurgia , Biópsia , Neoplasias Encefálicas/mortalidade , Neoplasias Encefálicas/cirurgia , Divisão Celular/fisiologia , Criança , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Índice Mitótico , Técnicas Estereotáxicas , Taxa de Sobrevida , Doenças Talâmicas/mortalidade , Doenças Talâmicas/cirurgia , Tálamo/patologia , Tálamo/cirurgia
9.
Acta méd. colomb ; 16(6): 289-303, nov.-dic. 1991. ilus, tab, graf
Artigo em Espanhol | LILACS | ID: lil-183207

RESUMO

En la unidad de Neurología del Centro Hospitalario San Juan de Dios de Bogotá, durante cuatro años (1986 a 1989), se estudiaron en forma consecutiva 25 pacientes con lesiones talámaticas no fatales. Se registraron los hallazgos neurológicos, neurosicológicos y neurooftalmológicos y los diagnósticos se confirmaron por tomografía computarizada (TC). Fueron 14 mujeres y 11 varones con una edad promedio de 52.5 y un rango de 25 a 84 años. La lesión talámica fue de origen vascular en 24 casos, ocho por infarto isquémico, cuatro por infarto hemorrágico y 12 con hematomas parenquimatosos. Diecisiete pacientes tenían hipertensión arterial sistémica y el único factor de riesgo en otros dos era el consumo de cocaína base (basuco). Ocho infartos se presentaron en el tálamo derecho, 12 en el izquierdo y cinco pacientes tuvieron lesiones bilaterales, uno de ellos con un glioma complobado por biopsia. En 5 pacientes con lesiónes bilateral se observó el síndrome del "Tope" de la arteria basilar, por compromiso del pedículo retromamilar; en todos ellos encontramos alteraciones sensitivomotoras, cerebelosas, oculomotoras bilaterales y demencia. Solamente un paciente presentó el clasicó síndrome de hiperpatía (Dejerine-Roussy). En los restantes se observaron asociaciones de síndromes sensitivomotores, cerebelosos, neurooftalmológicos, neuropsicológicos, y del comportamiento motor que remedan con frecuencia los hallazgos clínicos de la alteración cortical frontal, temporal o parietal.


Assuntos
Humanos , Doenças Talâmicas/classificação , Doenças Talâmicas/complicações , Doenças Talâmicas/diagnóstico , Doenças Talâmicas/epidemiologia , Doenças Talâmicas/etiologia , Doenças Talâmicas/fisiopatologia , Doenças Talâmicas/mortalidade , Doenças Talâmicas/tratamento farmacológico , Doenças Talâmicas , Doenças Talâmicas/terapia , Núcleos Talâmicos/anormalidades , Núcleos Talâmicos/fisiopatologia , Tálamo/anormalidades , Tálamo/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA